Experimental assessment of pro-lymphangiogenic growth factors in the treatment of post-surgical lymphedema following lymphadenectomy (Q34989014)

5 August 2017

Experimental assessment of pro-lymphangiogenic growth factors in the treatment of post-surgical lymphedema following lymphadenectomy (English)

1 reference

5 August 2017

1 reference

5

Molly Shoichet

1 reference

5 August 2017

Amy Baker

1

1 reference

5 August 2017

Harold Kim

2

1 reference

5 August 2017

John L Semple

3

1 reference

5 August 2017

Dan Dumont

4

1 reference

5 August 2017

Dalia Tobbia

6

1 reference

5 August 2017

Miles Johnston

7

1 reference

5 August 2017

8 September 2010

1 reference

5 August 2017

Breast Cancer Research

1 reference

5 August 2017

12

1 reference

5 August 2017

5

1 reference

5 August 2017

R70

1 reference

https://scigraph.springernature.com/pub.10.1186/bcr2638

5 August 2017

0 references

cites work

30-MONTH POST-BREAST CANCER TREATMENT LYMPHOEDEMA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096957

A new paradigm for local and sustained release of therapeutic molecules to the injured spinal cord for neuroprotection and tissue repair

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096957

Acquired lymphedema: an urgent need for adequate animal models

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096957

Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096957

Differential response of lymphatic, venous and arterial endothelial cells to angiopoietin-1 and angiopoietin-2.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096957

Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096957

Stable interaction between alpha5beta1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096957

CD44 cross-linking induces integrin-mediated adhesion and transendothelial migration in breast cancer cell line by up-regulation of LFA-1 (alpha L beta2) and VLA-4 (alpha4beta1).

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096957

Hyaluronan catabolism: a new metabolic pathway

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096957

Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096957

Devising a pathway for hyaluronan catabolism: are we there yet?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096957

VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096957

Insights into the molecular pathogenesis and targeted treatment of lymphedema

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096957

Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096957

Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096957

A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096957

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096957

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096957

Experimental assessment of autologous lymph node transplantation as treatment of postsurgical lymphedema.

8 July 2018

1 reference

An experimental model for the study of lymphedema and its response to therapeutic lymphangiogenesis

21 January 2018

1 reference

Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1.

21 January 2018

1 reference

An injectable drug delivery platform for sustained combination therapy.

21 January 2018

1 reference

Characterization of protein release from photocrosslinkable hyaluronic acid-polyethylene glycol hydrogel tissue engineering scaffolds

21 January 2018

1 reference

Critical roles of VEGF-C-VEGF receptor 3 in reconnection of the collecting lymph vessels in mice.

21 January 2018

1 reference

Postmastectomy lymphedema: long-term results following microsurgical lymph node transplantation

21 January 2018

1 reference

Local vascular access of radioprotein injected subcutaneously in healthy subjects and patients with breast cancer-related lymphedema

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096957

Therapeutic lymphangiogenesis with human recombinant VEGF-C.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096957

Phenotypic and genotypic heterogeneity in familial Milroy lymphedema

26 October 2018

1 reference

12 December 2020

Lymphatic drainage in the muscle and subcutis of the arm after breast cancer treatment

1 reference

12 December 2020

The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity

1 reference

12 December 2020

The role of lymphovenous communication in the development of postmastectomy lymphedema

1 reference

12 December 2020

Influence of adjuvant irradiation on the development of late arm lymphedema and impaired shoulder mobility after mastectomy for carcinoma of the breast

1 reference

12 December 2020

Lymphedema development and lymphatic function following lymph node excision in sheep

1 reference

12 December 2020

Identifiers

DOI

10.1186/BCR2638

1 reference

Dimensions Publication ID

5 August 2017

0 references

0 references

1 reference

5 August 2017

1 reference